Which research results in mice will help humans with multiple sclerosis? Now there's a way to tell

August 15, 2017 by Ellen Goldbaum, University at Buffalo
Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit: Marvin 101/Wikipedia

People with multiple sclerosis (MS) know all too well the frustration of hearing that success in treating the disease in mice had little or no effect in humans.

Unfortunately, with no large animal models for MS, results that suggest promising new treatments in mice often are ineffective in humans.

Now, University at Buffalo researchers have developed and successfully tested a method for determining how relevant to the human disease findings are from mouse models. The research was published Aug. 8 in Stem Cell Reports.

"This is an important resource for the field as it allows us to compare human and rodent cells, and provides a point of reference to understand whether or not gene expression patterns are conserved between species," said Fraser Sim, PhD, senior author and associate professor in the Department of Pharmacology and Toxicology in the Jacobs School of Medicine and Biomedical Sciences at UB. Co-first authors are Suyog U. Pol PhD, now a postdoctoral fellow, and Jessie J. Polanco, a doctoral candidate, both in the medical school.

MS trial failures

"There have been so many failures in clinical trials for MS when promising observations are translated from small animal models to the clinic," Sim said. "Our primary motivation was to try to understand, at a molecular level, how the human cells responsible for synthesizing myelin differ from their much-better-studied mouse counterparts."

MS and some other neurological diseases occur when there is damage to myelin – the fatty sheath that allows nerve cells to communicate. So the myelin-producing cells, called human oligodendrocyte progenitor cells, or OPCs, found in the brain and spinal cord have been a major focus of efforts to better understand MS and develop potential new treatments for it.

Sim explained that undifferentiated OPCs are frequently found in the brain lesions of MS patients, so boosting the differentiation of these cells could lead to myelination and a reduction of symptoms.

From OPCs to oligodendrocytes

One reason why so many fail may be because of fundamental differences in the types and levels of expressed between mice and humans. Sim and his colleagues addressed this question by performing gene-expression analysis on differentiating human OPCs.

"In this paper, we describe the transcriptional events that underlie how human OPCs develop into oligodendrocytes," said Sim.

To do it, they used a network analysis software tool called weighted gene coexpression network analysis (WCGNA). The software clusters together genes with similar patterns of expression. It also allows for analysis of both conserved and divergent gene expression between humans and rodents.

"WCGNA looks at the relationships between genes rather than absolute differences between conditions in any given experiment," Sim said.

He added that the information encoded in levels of gene expression increasing or decreasing is very reliable and reproducible.

"We performed WCGNA in exactly the same manner on cells isolated from mice, rats and humans, and prepared these in as close to matched conditions as possible, trying to keep things as similar as possible to facilitate this comparison," said Sim.

It turned out several of the genes the team had identified as relevant to human disease also are involved in mouse development and mouse models of myelin disease.

New myelin-repairing gene

Based on its findings from that analysis, the team had predicted that GNB4, a protein involved in signal transduction, would be involved in the development of OPCs in humans. The researchers found that over-production of GNB4, a protein involved in the transduction of extracellular signals, could cause human OPCs to rapidly undergo myelination when transplanted into a model for human cell therapy in MS.

"So this protein's expression in might ultimately become a therapeutic target, potentially promoting oligodendrocyte formation in MS patients," said Sim.

The approach also identified several other important candidates that play key roles in regulating the development of human oligodendrocytes.

Explore further: Enzyme in myelination process could lead to better understanding of neurological disorders

More information: Suyog U. Pol et al. Network-Based Genomic Analysis of Human Oligodendrocyte Progenitor Differentiation, Stem Cell Reports (2017). DOI: 10.1016/j.stemcr.2017.07.007

Related Stories

Enzyme in myelination process could lead to better understanding of neurological disorders

April 14, 2016
The removal of the enzyme Dnmt1 during oligodendrocyte progenitor cell (OPC) differentiation in the central nervous system resulted in inefficient myelin formation and neurological deterioration, including loss of control ...

Hidden herpes virus may play key role in multiple sclerosis, other brain disorders

July 10, 2017
The ubiquitous human herpesvirus 6 (HHV-6) may play a critical role in impeding the brain's ability to repair itself in diseases like multiple sclerosis. The findings, which appear in the journal Scientific Reports, may help ...

Mice stem cells guided into myelinating cells by the trillions

September 25, 2011
Scientists at Case Western Reserve University School of Medicine found a way to rapidly produce pure populations of cells that grow into the protective myelin coating on nerves in mice. Their process opens a door to research ...

MicroRNA treatment restores nerve insulation, limb function in mice with multiple sclerosis

March 27, 2017
Scientists partially re-insulated ravaged nerves in mouse models of multiple sclerosis (MS) and restored limb mobility by treating the animals with a small non-coding RNA called a microRNA.

'Master switch' for myelination in human brain stem cells is identified

June 30, 2014
Scientists at the University at Buffalo have identified the single transcription factor or "master switch" that initiates the critical myelination process in the brain. The research will be published online in Proceedings ...

Recommended for you

New technique helps uncover changes in ALS neurons

June 22, 2018
Northwestern Medicine scientists have discovered that some neurons affected by amyotrophic lateral sclerosis (ALS) display hypo-excitability, using a new method to measure electrical activity in cells, according to a study ...

Broken shuttle may interfere with learning in major brain disorders

June 22, 2018
Unable to carry signals based on sights and sounds to the genes that record memories, a broken shuttle protein may hinder learning in patients with intellectual disability, schizophrenia, and autism.

Watching stem cells repair spinal cord in real time

June 22, 2018
Monash University researchers have restored movement and regenerated nerves using stem cells in zebra fish where the spinal cord is severely damaged.

Scientists discover fundamental rule of brain plasticity

June 21, 2018
Our brains are famously flexible, or "plastic," because neurons can do new things by forging new or stronger connections with other neurons. But if some connections strengthen, neuroscientists have reasoned, neurons must ...

Waking up is hard to do: Prefrontal cortex implicated in consciousness

June 21, 2018
Philosophers have pondered the nature of consciousness for thousands of years. In the 21st century, the debate over how the brain gives rise to our everyday experience continues to puzzle scientists. To help, researchers ...

Researchers find mechanism behind choosing alcohol over healthy rewards

June 21, 2018
A new study links molecular changes in the brain to behaviours that are central in addiction, such as choosing a drug over alternative rewards. The researchers have developed a method in which rats learn to get an alcohol ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.